Search Results 401-410 of 3556 for 搜索引擎留痕工具咨询邮箱：lgooxc@hotmail.com
El Melik, Razan M. Pharm.D., BCACP, R.Ph. elmelik.razan@mayo.edu; Assistant Professor of Pharmacy. More about research at Mayo Clinic.
An attenuation map of the T/R head coil will be developed and evaluated in phantom experiments followed by the patient studies. The repeatability of generating ...
About this study. The PHAR is a multicenter, prospective registry of newly evaluated patients at PHCCs in the United States who have either PAH or CTEPH.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...
Gemcitabine hydrochloride may prevent tumor cells from multiplying by damaging their deoxyribonucleic acid (DNA) molecules that contain instructions for the ...
Evaluating an Interactive Medical Record Timeline (MeRLin) to Facilitate Historical Chart Review During New Patient Encounters in the ICU · Overview.
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and help kill them or carry cancer- ...
See the application selection process for Benefactor-Funded Research Established-Investigator Career Awards at Mayo Clinic's Center for Clinical and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.